Boeing to Start Voluntary Layoffs, Will Shed an Initial 2,500 Workers 
 

Boeing will this week announce about 2,500 voluntary layoffs in the first phase of broader cuts triggered by the coronavirus-driven collapse of global air travel.

 
France's Macron Orders Up Billions in Aid for Auto Industry 
 

The French government is taking steps to prop up France's auto industry amid a collapse in car purchases caused by the coronavirus crisis.

 
Sanofi to Offload Regeneron Stake 
 

Sanofi will raise up to $11.7 billion by selling almost its entire 20.6% stake in U.S. biotech Regeneron.

 
Infineon Raises EUR1B for Cypress Buy 
 

Infineon said its has raised about EUR1.06 billion through a share placement to partially fund its acquisition of Cypress Semiconductor.

 
Merck Does Deals to Develop Coronavirus Vaccines, Drug 
 

Drugmaker Merck said it is buying a privately held Austrian company to obtain one vaccine while joining with other groups on a second vaccine and an antiviral.

 
Boeing, Airbus Study Coronavirus on Flights 
 

The airplane makers are researching the coronavirus's behavior inside jetliners, part of the industry's effort to curb risks that have brought air traffic to a near standstill.

 
Amazon in Advanced Talks to Buy Self-Driving-Car Tech Company Zoox 
 

Amazon is in advanced talks to buy Zoox, a move that would expand its reach in autonomous-vehicle technology, people familiar with the matter say.

 
Amtrak Prepares to Cut 20% of Workforce 
 

Amtrak is preparing to cut up to 20% of its workforce in the next fiscal year as the national railroad continues to suffer from a huge decline in ridership as the coronavirus pandemic brought most travel to a halt.

 
SEC Fines Ares $1 Million for Compliance Failures 
 

Ares Management has agreed to pay $1 million to settle allegations that it bought stock in one of its portfolio companies while an Ares employee sat on that company's board and had access to inside information.

 
Biocon's CytoSorb Approved in India to Treat Critical Covid-19 Patients 
 

CytoSorb will be used to reduce pro-inflammatory cytokines levels in Covid-19 patients admitted to intensive care units who have confirmed or imminent respiratory failure.

 
 

(END) Dow Jones Newswires

May 27, 2020 03:15 ET (07:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.